Table of Contents

Statistical Analytics – How COVID-19 Vaccine Is Working Well

Last year’s pandemic almost had the world limping with harrowing losses. It makes billions of people around the globe suffer from lives and livelihoods disruption.

Ranging from day trading to household chores, everything was affected. However, we were able to gain considerable control over the situation with the help of the healthcare and other technological sectors.

However, despite the mass distribution of vaccines, the COVID-19 is still a considerable threat. Thus, we are still struggling, and achieving normalcy is yet a difficult milestone we need to accomplish.

21.1% of the world’s population has received at least one dose of the COVID-19 vaccine. The companies are distributing around 33.9 million doses daily. This number constitutes 2.5 million doses to date.

However, in low-income countries, only 0.8% of people have received the first dose. It can be a substantial amount of risk. Let’s take a quick look at how the COVID-19 vaccines have fared so far.

· Types of Vaccines

The WHO has approved one of China’s corona vaccines; it is permissible for usage worldwide. However, published trial data remain scarce. So far, vaccines (Sinopharm and Sinovac) have raised considerable attention.

China has administered about 892.77 million doses of the COVID-19 vaccine. At the same time, companies have supplied almost 2.39 billion doses of the vaccine worldwide.

The Centers for Disease Control and Prevention (CDC) offers you information regarding vaccines in the US. The center provides the following set of information.

Johnson & Johnson / Janssen – 18 years or older can get this vaccine. You can get fully vaccinated after two weeks of taking 1^st
Moderna – 18 years or older can get this vaccine. 4 weeks apart, you’ll be given two shots given 4. After 20 days, you can get your vaccination card.
Pfizer – BioNTech – 12 years or older can get this vaccine. You’ll get two shots at the interval of 3 weeks (21 days). You can claim your vaccination after the second short.

Tracking the COVID-19 vaccines in the US, over 53% of the nation’s population, more than 175 million people have received at least one dose of vaccine as reported by US Facts Org’s recent report. Furthermore, the US heat center distributed around 375 million doses. Out of which, the population utilizes 83%, which is equal to 312 million of the doses.

· Best Results

The CDC approves three vaccines for mass usage across the globe. See the following comparison of Pfizer, Moderna, and Johnson & Johnson vaccines.

During mid-April, the FDA and CDC instructed a pause in using the vaccine. This is because one of the contract production companies has contaminated 15 million doses. This becomes a serious threat for the patients to sue this vaccine on a large scale.

The Pfizer vaccine shows efficacy of 95% at preventing symptomatic COVID-19 infection after two doses. On the other hand, the Moderna vaccine is 94.1% effective. However, both the vaccine is effective after the completion of the second dose. On the contrary to these two approved vaccines, the J&J vaccine is struggling with legal issues. As a result, the drug authorities are not approving this vaccine for the masses.

READ MORE: Villain Perfume Review

· Problems and Challenges Faced

Lancet is the world’s oldest and best-known medical journals which are known for its credibility. It identifies the following challenges and problems associated with the COVID-19 vaccination:

Underinvestment is one of the biggest issues for vaccine development. Despite the fact, in less than 12 months, several manufacturers have successfully developed the COVID-19 vaccine. Nevertheless, the world needs more COVID-19 vaccines than it has recorded for any other vaccine history. This is a dire situation indeed where global vaccine immunity is the primary goal.
Pricing of the COVID-19 is also a huge concern since low-income companies are extremely vulnerable these days. Even in rich and high-income countries, it is important to ensure the provision of COVID-19 vaccines to the poor and marginalized populations.
Next is the global distribution of the vaccine. The pre-orders made by first world countries create a challenge to achieve timely and universal access to vaccines. Certain decisions are in progress regarding the distribution. But in the case of constrained supply with demand exceeding current and projected levels of output.

Even with all the above challenges are mitigated, the problem of people accepting the vaccines is still a cliffhanger. The data collected from a 32-country survey from October to December 2020 denotes the following results:

China – 91% acceptance
Denmark – 87% acceptance
India – 91% acceptance
Serbia – 38% acceptance (lowest)
Vietnam – 98% acceptance (highest)

· The Future of Vaccines

The world is hoping to beat back the virus with COVID-19 vaccines. However, imprinting is a phenomenon that is the latest concern for the scientist. This phenomenon is also known as a quirk in our biological system. It is a future iteration of vaccines that might not prove to be as effective as they are today.

In medical terminology, the second name of quirk is original antigenic sin. This relates to how we respond to some pathogens.

While a Healthline article claims that the future of COVID-19 and other pandemic vaccines may turn out to be in the form of pills. The research team at The Atlantic states that variants pose a serious threat. But, with over 165 million people and counting inoculated in the United States, COVID-19 mutations are another story altogether.

Testing and ferreting them out will help us make more effective vaccines. For example, the CDC alone has documentation of 10,262 post-vaccination infections.

Currently, the CDC is following a revised guideline for monitoring post-vaccination infections, which is also a pragmatic approach.

If more cases or frequency of variations is observed that exceeds 5% of total cases, then testing for these variations can become an obligation in the future. If this happens, we will observe several labs soliciting specimens from around the nation and sequencing them for future vaccines.

Young learners at Student Essay UK can do their research regarding vaccines. It will enable them not to get victimized by the false information spread online about the COVID-19 vaccines.

READ MORE: Muuchstac Face Wash Review

· Are We Prepared for another Pandemic?

People might think we have seen the worst. However, visionaries like Bill Gates think that this a learning time for the whole world to prepare for a similar situation in the near future. Our world is changing, and global warming/climate change is nothing to be scoffed at.

This is why the important question right now is, are we ready for the next pandemic?

At Scientific American, experts believe that real-world data holds the key for all of us to prepare for the next pandemic. Within a period of 6 months, over 23,500 papers are published on similar subjects.

· Debunking Myths about Vaccine

Here are some common myths about COVID-19 vaccines debunked:

Effect on women’s fertility: COVID-19 vaccine encourages the human body to create copies of spike protein found on the virus’ surface. As a result, it makes the immune system stronger.
COVID-19 survivors don’t need vaccine: vaccination will benefit COVID-19 survivors since re-infection is still possible even if they didn’t get sick the first time.
The vaccine has the virus – no COVID-19 vaccine will give you the virus. In fact, all vaccines are designed to help your body fight back the virus and stop infections.
Side effects are dangerous: the Pfizer and Moderna COVID-19 vaccines do have side effects. But all of them have been tested to last for a very short term, and there is nothing dangerous about them.

Conclusion

The only logical conclusion to all of this pandemic madness lies with the large portion of the world becoming immune to the virus. It is the safest way to accomplish this is with the help of the vaccine. Humanity has often relied on the progress of vaccines in the past. This was to bring an end to mortally damaging viruses and infectious diseases. The solution is in our hand’s reach.

However, the biggest challenge now is to make sure that vaccines are made available to people around the globe. Especially those countries that are struggling to keep up and have low incomes. The key doesn’t lie in just vaccinating the rich countries but to ensure that population in all countries are effectively treated in the most efficient manner possible. Wishing you all the best of health, let’s join our hands and defeat this evil for good. Cheers and Banzai!